Monoclonal antibody
Type Whole antibody
Source Humanized
Target lymphotoxin alpha
Clinical data
ATC code none
CAS Number 1202526-59-7 N
ChemSpider none
KEGG D10187 N
Chemical and physical data
Formula C6436H9910N1710O2004S44
Molar mass 144.7 kDa
 NYesY (what is this?)  (verify)

Pateclizumab is an immunomodulator. It binds to lymphotoxin alpha.[1][2]

This drug was developed by Genentech/Roche.


  1. World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2).
  2. Statement On A Nonproprietary Name Adopted By The USAN Council - Pateclizumab, American Medical Association.

This article is issued from Wikipedia - version of the 11/17/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.